Risk factors for and management of cognitive dysfunction in multiple sclerosis

[1]  Maja O’Connor.  LONGITUDINAL STUDY , 2013 .

[2]  M. Sá,et al.  Cognitive Dysfunction in Multiple Sclerosis , 2012, Front. Neur..

[3]  E. Kaplan,et al.  Delis-Kaplan Executive Function System , 2012 .

[4]  R. Rudick,et al.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS , 2011, Neurology.

[5]  J. DeLuca,et al.  L-amphetamine improves memory in MS patients with objective memory impairment , 2011, Multiple sclerosis.

[6]  L R Muenz,et al.  Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis , 2011, Neurology.

[7]  R. Benedict,et al.  Effects of acute relapses on neuropsychological status in multiple sclerosis patients , 2011, Journal of Neurology.

[8]  Eben S. Schwartz,et al.  The NEO-FFI in Multiple Sclerosis: Internal Consistency, Factorial Validity, and Correspondence Between Self and Informant Reports , 2011, Assessment.

[9]  M. Ramanathan,et al.  The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis. , 2011, Pathophysiology : the official journal of the International Society for Pathophysiology.

[10]  A. Minagar.  Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up , 2011 .

[11]  G. Wylie,et al.  Premorbid cognitive leisure independently contributes to cognitive reserve in multiple sclerosis , 2010, Neurology.

[12]  C. Pozzilli,et al.  Cognitive and psychosocial features in childhood and juvenile MS , 2010, Neurology.

[13]  R. Benedict,et al.  Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline , 2010, The Clinical neuropsychologist.

[14]  L. Kappos,et al.  Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks , 2010, Multiple sclerosis.

[15]  R. Kane,et al.  T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis , 2010, Multiple sclerosis.

[16]  Z Khaleeli,et al.  Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study , 2010, Multiple sclerosis.

[17]  A. Feinstein,et al.  APOE ε4 and the cognitive genetics of multiple sclerosis , 2010, Neurology.

[18]  A. Iudice,et al.  Reliability, practice effects, and change indices for Rao’s brief repeatable battery , 2010, Multiple sclerosis.

[19]  M. Brown,et al.  Multiple Sclerosis Susceptibility-Associated SNPs Do Not Influence Disease Severity Measures in a Cohort of Australian MS Patients , 2010, PloS one.

[20]  A. Feinstein,et al.  APOE ε4 and Cognitive Dysfunction in Multiple Sclerosis: A Review , 2010 .

[21]  L. Passamonti,et al.  The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: An imaging genetic study , 2010, Behavioural Brain Research.

[22]  R. Benedict,et al.  Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test , 2010, Multiple sclerosis.

[23]  G. Wylie,et al.  Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve , 2009, Brain : a journal of neurology.

[24]  M. Trent,et al.  Results of a randomized controlled trial of a brief behavioral intervention for pelvic inflammatory disease in adolescents. , 2009, Journal of pediatric and adolescent gynecology.

[25]  S. Hussein,et al.  Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study. , 2010, Folia biologica.

[26]  S. Sorbi,et al.  ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis , 2009, Acta neurologica Scandinavica.

[27]  S. Lynch,et al.  Cognitive aging in patients with multiple sclerosis: a cross-sectional analysis of speeded processing. , 2009, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[28]  R. Benedict,et al.  The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) , 2009, Journal of the International Neuropsychological Society.

[29]  T. Kilpatrick,et al.  Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy , 2009, Neurology.

[30]  N. Staff,et al.  Multiple sclerosis with predominant, severe cognitive impairment. , 2009, Archives of neurology.

[31]  B. Weinstock-Guttman,et al.  Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis , 2009, Multiple sclerosis.

[32]  G. Wylie,et al.  Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis , 2009, Journal of the International Neuropsychological Society.

[33]  Stephen M. Rao,et al.  Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS , 2009, Multiple sclerosis.

[34]  G Luccichenti,et al.  Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study , 2009, Multiple sclerosis.

[35]  F. Barkhof,et al.  Accumulation of cortical lesions in MS: relation with cognitive impairment , 2009, Multiple sclerosis.

[36]  T. Dwyer,et al.  Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis , 2009, Journal of Neurology.

[37]  M. Bear,et al.  The effects of l-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial , 2009, Journal of Neurology.

[38]  G. Koutsis,et al.  An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis , 2009, Multiple sclerosis.

[39]  A. Achiron,et al.  Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process , 2009, Journal of the Neurological Sciences.

[40]  L. Messinis,et al.  MULTIPLE SCLEROSIS AND CANNABIS: A COGNITIVE AND PSYCHIATRIC STUDY , 2009, Neurology.

[41]  J. DeLuca,et al.  Cognitive impairment in multiple sclerosis , 2008, The Lancet Neurology.

[42]  D. Ramasamy,et al.  Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[43]  R. Rudick,et al.  Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.

[44]  V. Shaygannejad,et al.  Effects of Rivastigmine on Memory and Cognition in Multiple Sclerosis , 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[45]  F. Barwick,et al.  Depression in multiple sclerosis: Review and theoretical proposal , 2008, Journal of the International Neuropsychological Society.

[46]  A. Feinstein,et al.  Multiple sclerosis and cannabis , 2008, Neurology.

[47]  Robert Zivadinov,et al.  Cortical atrophy and personality in multiple sclerosis. , 2008, Neuropsychology.

[48]  J. DeLuca,et al.  The relationship between cognitive deficits and everyday functional activities in multiple sclerosis. , 2008, Neuropsychology.

[49]  Stephen L. Hauser,et al.  The genetics of multiple sclerosis: SNPs to pathways to pathogenesis , 2008, Nature Reviews Genetics.

[50]  B. Weinstock-Guttman,et al.  Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire , 2008, Multiple sclerosis.

[51]  R. Benedict,et al.  Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients , 2008, Journal of Neurology.

[52]  M. Wallin,et al.  Treatment of Multiple Sclerosis–Related Cognitive Problems With Adjunctive Modafinil , 2008 .

[53]  R. Benedict,et al.  Influence of recruitment and participation bias in neuropsychological research among MS patients , 2008, Journal of the International Neuropsychological Society.

[54]  J. DeLuca,et al.  Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature. , 2008, Archives of physical medicine and rehabilitation.

[55]  Kyle C. Kern,et al.  Regional hippocampal atrophy in multiple sclerosis. , 2008, Brain : a journal of neurology.

[56]  Richard H. Price,et al.  Black Holes , 1997 .

[57]  M. Ramanathan,et al.  Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. , 2007, Human molecular genetics.

[58]  P. Duberstein,et al.  The Distressed personality type: replicability and general health associations , 2007 .

[59]  C R G Guttmann,et al.  Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.

[60]  Rohit Bakshi,et al.  Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis , 2007, NeuroImage.

[61]  R. Sperling,et al.  Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis , 2007, Multiple sclerosis.

[62]  K. Koivisto,et al.  PASAT in Detecting Cognitive Impairment in Relapsing-Remitting MS , 2007, Applied neuropsychology.

[63]  P. Duberstein,et al.  Personality and Medical Illness Burden Among Older Adults in Primary Care , 2007, Psychosomatic medicine.

[64]  G. Koutsis,et al.  APOE ε4 is associated with impaired verbal learning in patients with MS , 2007, Neurology.

[65]  C. Hawkes.  Smoking is a risk factor for multiple sclerosis: a metanalysis , 2007, Multiple sclerosis.

[66]  Robert Zivadinov,et al.  Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis , 2007, Multiple sclerosis.

[67]  R. Benedict,et al.  Validity of the Wisconsin Card Sorting and Delis–Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis , 2007, Journal of clinical and experimental neuropsychology.

[68]  B. Parmenter,et al.  Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms , 2007, Multiple sclerosis.

[69]  F. Munschauer,et al.  Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test , 2007, Multiple sclerosis.

[70]  C. Hart,et al.  Neuropsychological deficits in long-term frequent cannabis users , 2006, Neurology.

[71]  S. Hauser,et al.  The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration , 2006, Neuron.

[72]  Robert Zivadinov,et al.  Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. , 2006, Archives of neurology.

[73]  R. Benedict,et al.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) , 2006, Journal of the International Neuropsychological Society.

[74]  Emilio Portaccio,et al.  Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies , 2006, Journal of the Neurological Sciences.

[75]  C. Polman,et al.  Cognitive impairment and decline in different MS subtypes , 2006, Journal of the Neurological Sciences.

[76]  R. Marrie,et al.  Does multiple sclerosis–associated disability differ between races? , 2006, Neurology.

[77]  Sandro Sorbi,et al.  Benign multiple sclerosis , 2006, Journal of Neurology.

[78]  O Garcea,et al.  Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test , 2006, Multiple sclerosis.

[79]  P. Pasqualetti,et al.  The Symbol Digit Modalities Test - Oral version: Italian normative data. , 2006, Functional neurology.

[80]  Y. Stern.  Cognitive Reserve and Alzheimer Disease , 2006, Alzheimer disease and associated disorders.

[81]  S. Malefaki,et al.  Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI , 2006, Neurology.

[82]  P. Pasqualetti,et al.  Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis , 2006, Multiple sclerosis.

[83]  S. Sorbi,et al.  Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. , 2006, Journal of neurology.

[84]  A. Thompson,et al.  A longitudinal study of cognition in primary progressive multiple sclerosis. , 2005, Brain : a journal of neurology.

[85]  R. Benedict.  Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis , 2005, Journal of the International Neuropsychological Society.

[86]  R. Benedict,et al.  Interpreting patient/informant discrepancies of reported cognitive symptoms in MS , 2005, Journal of the International Neuropsychological Society.

[87]  Rohit Bakshi,et al.  Regional lobar atrophy predicts memory impairment in multiple sclerosis. , 2005, AJNR. American journal of neuroradiology.

[88]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[89]  R. Bakshi,et al.  Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change , 2005, Journal of the Neurological Sciences.

[90]  H. Amièva,et al.  Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[91]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[92]  Jason Steffener,et al.  Cerebral Activation Patterns During Working Memory Performance in Multiple Sclerosis Using fMRI , 2005, Journal of clinical and experimental neuropsychology.

[93]  J. DeLuca,et al.  Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial , 2005, Multiple sclerosis.

[94]  A. R.,et al.  Review of literature , 1969, American Potato Journal.

[95]  L. Krupp,et al.  Donepezil improved memory in multiple sclerosis in a randomized clinical trial , 2004, Neurology.

[96]  C. Caltagirone,et al.  Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis , 2004, Journal of Neurology.

[97]  C. Polman,et al.  Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS , 2004, Neurology.

[98]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[99]  Rohit Bakshi,et al.  Correlating Brain Atrophy With Cognitive Dysfunction, Mood Disturbances, and Personality Disorder in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[100]  J. DeLuca,et al.  Is Speed of Processing or Working Memory the Primary Information Processing Deficit in Multiple Sclerosis? , 2004, Journal of clinical and experimental neuropsychology.

[101]  S. Sorbi,et al.  Influence of Apolipoprotein E ϵ4 Genotype on Brain Tissue Integrity in Relapsing-Remitting Multiple Sclerosis , 2004 .

[102]  P. Matthews,et al.  Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4 , 2004, Annals of neurology.

[103]  Caterina Mainero,et al.  fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis , 2004, NeuroImage.

[104]  N. Lobaugh,et al.  Structural brain abnormalities in multiple sclerosis patients with major depression , 2004, Neurology.

[105]  Rohit Bakshi,et al.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.

[106]  Rohit Bakshi,et al.  Role of MRI in multiple sclerosis I: inflammation and lesions. , 2004, Frontiers in bioscience : a journal and virtual library.

[107]  Zhengrong Liang,et al.  Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients , 2003, Neurology.

[108]  Rohit Bakshi,et al.  A semiautomated measure of whole-brain atrophy in multiple sclerosis , 2003, Journal of the Neurological Sciences.

[109]  R. Aupperle,et al.  Sex Differences in Cognitive Impairment in Multiple Sclerosis , 2002, The Clinical neuropsychologist.

[110]  Ralph H B Benedict,et al.  Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach , 2002, The Clinical neuropsychologist.

[111]  M. Rovaris,et al.  Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging , 2002, Journal of the Neurological Sciences.

[112]  R. Bakshi,et al.  Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[113]  Dirk Berg-Schlosser,et al.  Cross-Sectional and Longitudinal Analysis , 2002 .

[114]  P. Pasqualetti,et al.  Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine , 2001, Multiple sclerosis.

[115]  S. Sorbi,et al.  Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. , 2001, Archives of neurology.

[116]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[117]  R. Bakshi,et al.  Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. , 2001, Archives of neurology.

[118]  J. Fisk,et al.  Information Processing Efficiency in Patients with Multiple Sclerosis , 2000, Journal of clinical and experimental neuropsychology.

[119]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[120]  R. Bakshi,et al.  Intraventricular CSF pulsation artifact on fast fluid-attenuated inversion-recovery MR images: analysis of 100 consecutive normal studies. , 2000, AJNR. American journal of neuroradiology.

[121]  M Rovaris,et al.  Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[122]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[123]  A. Quattrone,et al.  APOE and risk of cognitive impairment in multiple sclerosis , 1999, Acta neurologica Scandinavica.

[124]  F. Barkhof,et al.  The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis , 1999, Neurology.

[125]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[126]  R. Herndon,et al.  A longitudinal study of brain atrophy in relapsing multiple sclerosis , 1999, Neurology.

[127]  A. Thompson,et al.  Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. , 1999, Brain : a journal of neurology.

[128]  B D Trapp,et al.  Axonal pathology in multiple sclerosis: relationship to neurologic disability. , 1999, Current opinion in neurology.

[129]  A J Thompson,et al.  Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome , 1999, Multiple sclerosis.

[130]  J K Udupa,et al.  Correlation of volumetric magnetization transfer imaging with clinical data in MS , 1998, Neurology.

[131]  J. DeLuca,et al.  Acquisition and storage deficits in multiple sclerosis. , 1998, Journal of clinical and experimental neuropsychology.

[132]  L. Leocani,et al.  Clinical, neurophysiological, and magnetic resonance imaging correlations in multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.

[133]  J S Wolinsky,et al.  Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability , 1998, Neurology.

[134]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[135]  R Kikinis,et al.  Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. , 1997, Archives of neurology.

[136]  F. Barkhof,et al.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.

[137]  C. Bever,et al.  Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients , 1996, Neurology.

[138]  Ralph H. B. Benedict,et al.  Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. , 1996 .

[139]  M. Sliwinski,et al.  The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. , 1996, Archives of neurology.

[140]  L. Grattan,et al.  The brief repeatable battery of neuropsychological tests for multiple sclerosis: a preliminary serial study , 1995, Multiple sclerosis.

[141]  Massimo Filippi,et al.  Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis , 1995, Journal of the Neurological Sciences.

[142]  J. Greene.  Contributions to Neuropsychological Assessment , 1995 .

[143]  B. Weinstock-Guttman,et al.  A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients , 1995 .

[144]  C. Polman,et al.  The effects of 4‐aminopyridine on cognitive function in patients with multiple sclerosis , 1994, Neurology.

[145]  C. Bever,et al.  The effects of 4‐aminopyridine in multiple sclerosis patients , 1994, Neurology.

[146]  R. Mayeux,et al.  Influence of education and occupation on the incidence of Alzheimer's disease. , 1994, JAMA.

[147]  G. Comi,et al.  Influence of clinical variables on neuropsychological performance in multiple sclerosis. , 1994, European neurology.

[148]  P. Duquette,et al.  Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. , 1993 .

[149]  W. Mcdonald,et al.  The pathological evolution of multiple sclerosis , 1992, Neuropathology and applied neurobiology.

[150]  S. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[151]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[152]  Evon M. O. Abu-Taieh,et al.  Comparative Study , 2020, Definitions.

[153]  E. Kaplan,et al.  Guidelines for neuropsychological research in multiple sclerosis. , 1990, Archives of neurology.

[154]  S. Rao,et al.  On the nature of memory disturbance in multiple sclerosis. , 1989, Journal of clinical and experimental neuropsychology.

[155]  V. Haughton,et al.  Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis , 1989, Neurology.

[156]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[157]  S G Waxman,et al.  Membranes, myelin, and the pathophysiology of multiple sclerosis. , 1982, The New England journal of medicine.

[158]  D. Gronwall.  Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion , 1977, Perceptual and motor skills.

[159]  HERMAN BUSCHKE,et al.  Evaluating storage, retention, and retrieval in disordered memory and learning , 1974, Neurology.

[160]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.

[161]  J Barbizet,et al.  Clinical and psychometrical study of a patient with memory disturbances. , 1968, International journal of neurology.

[162]  Arthur L. Benton,et al.  Word fluency and brain damage , 1967 .

[163]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[164]  J. Charcot,et al.  Lectures on the diseases of the nervous system: delivered at La Salpêtrìere , 2009 .